|
Geng Wu, Professor
Shanghai Jiao Tong University, Life Sciences
Area of Focus
Anticancer | Biomolecular | Drug Development | Protein Design | Synthesis | Molecular Biology | Structural Biology | Cancer Therapy | Pharmaceuticals | Biochemistry |
|
Jing Liu, Professor
Central South University, Life Sciences
Area of Focus
Hematopoiesis | Malignancy | Molecular Mechanisms | Cancer Therapy | Tumor Resistance | Tumor Immunology | Stem Cells | Autophagy | Drug Development | Erythroid Differentiation |
|
Weiqiang Lu, Researcher, Doctoral Supervisor
East China Normal University , Life Sciences
Area of Focus
Gpcr | Tumor | Immune Regulation | Signaling | Cell Signaling | Molecular Mechanisms | Drug Development | Cancer Therapy | Receptor | Pharmacology | Clinical Trials | Molecular Targets | Receptor Antagonists | Medicinal Chemistry | Tumor Environment | Innovation |
|
Geng Wu, Professor
Shanghai Jiao Tong University , Life Sciences
Area of Focus
Anticancer | Biomolecular | Drug Development | Protein Design | Nucleic Acid Synthesis | Artificial Cells | Structural Biology | Cancer Therapy | Molecular Biology | Biochemistry |
|
Yunhua Peng, Associate Professor
Xi'an Jiaotong University , Life Sciences
Area of Focus
Phosphorylation | Ubiquitination | Deubiquitination | Protein Degradation | Cancer Therapy | Metabolic Reprogramming | Tumor Environment | Drug Development | Nutrient Screening | Mitochondrial Function |
|
Xuejun Jiang, Doctoral Supervisor
University of Chinese Academy of Sciences , Life Sciences
Area of Focus
Autophagy | Egfr | Signaling Pathways | Fungal Metabolites | Cell Death | Cancer | Drug Development | Molecular Biology | Biochemistry | Microbiology |
|
Zichun Hua, Director
Nanjing University, Life Sciences
Area of Focus
Microbial Drugs | Tumor Immunotherapy | Peptide Engineering | Protein Structure | Cell Apoptosis | Drug Development | Biotechnology | Nanomedicine | Cancer Therapy | Biopharmaceuticals |
|
Si Qing Zhang, Professor
Xiamen University, Life Sciences
Area of Focus
Cell Cycle Regulation | Oncogenes | Tumor Suppressor Genes | Apoptosis | Programmed Cell Death | Signal Transduction | Bcl-2 Family Proteins | Dna Damage | Cancer Therapy | Nf-Κb |
|
Yong Li, Professor, Doctoral Supervisor
Xiamen University, Life Sciences
Area of Focus
Drug Development | Nuclear Receptors | Metabolic Diseases | Protein Structure | Signaling Pathways | Therapeutic Strategies | Molecular Mechanisms | Drug Repositioning | Structure-Activity Relationship | Pharmacology |
